when does semaglutide start to suppress appetite How Long for Appetite? How Long Does it Take

Direct answer: Both medications support medical weight loss, but tirzepatide targets an additional hormone pathway

It is essential to note that 2.5 mg is not a standard FDA-approved dose for either Ozempic or Wegovy

Constipation, nausea, and fatigue often decrease with a GLP-1-only approach

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate